Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value
IntroductionThe aim of this study was to estimate the social value of a tight and early control of patients with type 2 diabetes during the 5 years after diagnosis in Spain, compared to higher hemoglobin A1c (HbA1c) goals.MethodsAn economic model based on the scientific literature was used to estima...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1511108/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850118157082034176 |
|---|---|
| author | María Merino Paulina Maravilla-Herrera Sara Artola Sara Artola Javier Escalada Javier Escalada Antonio Pérez Antonio Pérez Antonio Pérez Juantxo Remón José L. Trillo-Mata Joan A. Vallès-Callol Álvaro Hidalgo-Vega Álvaro Hidalgo-Vega |
| author_facet | María Merino Paulina Maravilla-Herrera Sara Artola Sara Artola Javier Escalada Javier Escalada Antonio Pérez Antonio Pérez Antonio Pérez Juantxo Remón José L. Trillo-Mata Joan A. Vallès-Callol Álvaro Hidalgo-Vega Álvaro Hidalgo-Vega |
| author_sort | María Merino |
| collection | DOAJ |
| description | IntroductionThe aim of this study was to estimate the social value of a tight and early control of patients with type 2 diabetes during the 5 years after diagnosis in Spain, compared to higher hemoglobin A1c (HbA1c) goals.MethodsAn economic model based on the scientific literature was used to estimate the 5-year social value of maintaining tight and early type 2 diabetes control, i.e., keeping HbA1c levels <6.5%, during the 5 years after diagnosis in Spain, compared to non-tight control. Areas of analysis included healthcare resource utilization, the presence of complications, quality of life, and mortality. The outcomes corresponding to these two types of control (tight vs. non-tight) were multiplied by their unit cost or financial proxy to obtain the economic impact associated with each type of control. Social value was estimated as the reduction in the economic impact of a non-tight control when tight control is implemented and maintained. The results are expressed in euros for the year 2021.ResultsThe economic impact of tight control during the first 5 years after type 2 diabetes diagnosis was estimated to be €1,010 million in Spain (€13,473 per patient), which is lower than the impact of non-tight control, which was estimated to be €1,127 million (€16,122 per patient) during the same period.ConclusionMaintaining tight and early control of type 2 diabetes during the first 5 years after diagnosis could generate a positive social value of €2,649 per patient over that period, in terms of better health outcomes, increased quality of life, and decreased premature deaths. |
| format | Article |
| id | doaj-art-8f16fcd98d6e468d8db2c6363fdf96ad |
| institution | OA Journals |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-8f16fcd98d6e468d8db2c6363fdf96ad2025-08-20T02:35:56ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-07-011310.3389/fpubh.2025.15111081511108Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social valueMaría Merino0Paulina Maravilla-Herrera1Sara Artola2Sara Artola3Javier Escalada4Javier Escalada5Antonio Pérez6Antonio Pérez7Antonio Pérez8Juantxo Remón9José L. Trillo-Mata10Joan A. Vallès-Callol11Álvaro Hidalgo-Vega12Álvaro Hidalgo-Vega13Department of Health Outcomes Research, Weber, Madrid, SpainDepartment of Health Outcomes Research, Weber, Madrid, SpainJosé Marvá Health Centre, Madrid, SpainRed de Grupos de Estudio en Atención Primaria de Salud (redGDPS) Foundation, Madrid, SpainDepartment of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, SpainCentro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, SpainDepartment of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas – CIBERDEM, Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, Universitat Autónoma de Barcelona (UAB), Barcelona, SpainFederación Española de Diabetes, Madrid, Spain0Pharmacy Service of Health Area Malvarrosa Clinical Department, Conselleria de Sanitat, Valencia, Spain1Institut Català de la Salut, Barcelona, Spain2Department of Economic Analysis and Finances, University of Castilla-La Mancha, Toledo, Spain3Fundación Weber, Madrid, SpainIntroductionThe aim of this study was to estimate the social value of a tight and early control of patients with type 2 diabetes during the 5 years after diagnosis in Spain, compared to higher hemoglobin A1c (HbA1c) goals.MethodsAn economic model based on the scientific literature was used to estimate the 5-year social value of maintaining tight and early type 2 diabetes control, i.e., keeping HbA1c levels <6.5%, during the 5 years after diagnosis in Spain, compared to non-tight control. Areas of analysis included healthcare resource utilization, the presence of complications, quality of life, and mortality. The outcomes corresponding to these two types of control (tight vs. non-tight) were multiplied by their unit cost or financial proxy to obtain the economic impact associated with each type of control. Social value was estimated as the reduction in the economic impact of a non-tight control when tight control is implemented and maintained. The results are expressed in euros for the year 2021.ResultsThe economic impact of tight control during the first 5 years after type 2 diabetes diagnosis was estimated to be €1,010 million in Spain (€13,473 per patient), which is lower than the impact of non-tight control, which was estimated to be €1,127 million (€16,122 per patient) during the same period.ConclusionMaintaining tight and early control of type 2 diabetes during the first 5 years after diagnosis could generate a positive social value of €2,649 per patient over that period, in terms of better health outcomes, increased quality of life, and decreased premature deaths.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1511108/fullsocioeconomic impacttype 2 diabetesglycemic controlmonitoringcomplicationshospitalizations |
| spellingShingle | María Merino Paulina Maravilla-Herrera Sara Artola Sara Artola Javier Escalada Javier Escalada Antonio Pérez Antonio Pérez Antonio Pérez Juantxo Remón José L. Trillo-Mata Joan A. Vallès-Callol Álvaro Hidalgo-Vega Álvaro Hidalgo-Vega Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value Frontiers in Public Health socioeconomic impact type 2 diabetes glycemic control monitoring complications hospitalizations |
| title | Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value |
| title_full | Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value |
| title_fullStr | Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value |
| title_full_unstemmed | Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value |
| title_short | Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value |
| title_sort | tight and early hba1c control in patients with type 2 diabetes mellitus in spain quantifying the social value |
| topic | socioeconomic impact type 2 diabetes glycemic control monitoring complications hospitalizations |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1511108/full |
| work_keys_str_mv | AT mariamerino tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT paulinamaravillaherrera tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT saraartola tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT saraartola tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT javierescalada tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT javierescalada tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT antonioperez tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT antonioperez tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT antonioperez tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT juantxoremon tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT joseltrillomata tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT joanavallescallol tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT alvarohidalgovega tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue AT alvarohidalgovega tightandearlyhba1ccontrolinpatientswithtype2diabetesmellitusinspainquantifyingthesocialvalue |